ALC - Alcon AG logo

ALC

Alcon AG

Revenue grew 100% of years5Y
Hold

Alcon AG researches, develops, manufactures, and sells eye care products globally. Its offerings include surgical equipment, intraocular lenses, refractive surgery solutions, and vision care products like contact lenses and ocular health treatments.

βš•οΈ Healthcare NYSE Listed 2019 $ USD
$1,000 invested 5 years ago β†’$1,060today

Score Overview

1 Year
Score
Net Growth-16.80%
Net TrendShrank
Net Income Consistencyβ€”
Rev Growth1.73%
Rev TrendGrew
Revenue Consistencyβ€”
5 Years
Score6.5
Net Growth116.84%
Net Trend40%
Net Income Consistencyβ€”
Rev Growth27.63%
Rev TrendEvery year
Revenue Consistencyβ€”
All Time
Score
Net Growth224.29%
Net Trend57%
Net Income Consistency
Rev Growth40.94%
Rev Trend86%
Revenue Consistency

See the full market ranking β†’

Alcon AG fundamental performance

Between 2020 and 2025, revenue grew from $ 6.83B to $ 10.40B and net income went from -$ 531M to $ 980M. Revenue increased in every one of those 5 years; net income in 2.

Alcon AG currently holds a 5-year HDB Score of 6.5 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 73.58β€”
1 Year2025-08-12
$ 85.62-14.06%
5 Years2021-08-12
$ 69.426.00%
All Time2019-04-09
$ 56.8629.40%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 10.58B$ 815M$ 1.66B
2025$ 10.40B$ 980M$ 1.60B
2024$ 9.91B$ 1.01B$ 1.83B
2023$ 9.45B$ 974M$ 1.10B
2022$ 8.71B$ 335M$ 980M
2021$ 8.29B$ 376M$ 1.57B
2020$ 6.83B-$ 531M$ 1.56B
IPO2019$ 7.50B-$ 656M$ 855M

Explore beyond ALC

You're looking at Alcon AG. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies